In summary, the serum total APOA1-UP level was inversely correlated with the presence of ischemic stroke, and APOA1-UP can be used as a diagnostic biomarker for acute ischemic stroke at early stage, with a sensitivity of 90.63% and a specificity of 97.14%. Here, APOA1 is linked to ischemic stroke.